I think CUDC-101 is definitely an interesting "drug". I just think it's a way off.
I'd like to see some more trial results (positive of course) come out for Vismo which will allow me to get out with a really nice gain (before they dilute, again, of course). Not stoked on this management team, at all. Clueless when it comes to financing, and who to finance with.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.